Printer Friendly
The Free Library
5,677,474 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Diagnostic Systems Laboratories Inc. Acquires UK-Based Oxford Bio-Innovation.


Business Editors/Health & Medical Writers

BIOWIRE2K

WEBSTER, Texas--(BW HealthWire)--Nov. 8, 2001

Diagnostic Systems Laboratories Inc. (DSL DSL
 in full Digital Subscriber Line

Broadband digital communications connection that operates over standard copper telephone wires. It requires a DSL modem, which splits transmissions into two frequency bands: the lower frequencies for voice (ordinary
) announced today that it has acquired Oxford Bio-Innovation Ltd. (OBI), a joint venture between Oxford Brookes University Oxford Brookes University is a public university in Oxford, England. Overview
The University has roots in Oxford that go back to 1865 (when it was known as the Oxford School of Art). The present student body is 19,000.
 and Serotec Ltd.

Based in Oxford, England, OBI was founded in 1998 and is a leader in the development, manufacture and marketing of diagnostic and research products for the measurement of Inhibin in·hib·in
n.
A peptide hormone secreted by the follicular cells of the ovary and the Sertoli cells of the testis that inhibits secretion of follicle stimulating hormone from the anterior pituitary.
 and Activin activin /ac·ti·vin/ (ak´ti-vin) a nonsteroidal regulator synthesized in the pituitary glands and gonads that stimulates the secretion of follicle-stimulating hormone.

ac·ti·vin
n.
 levels. The OBI product range includes kits and reagents for Inhibin A, Inhibin B, Activin and Pro Alpha C. The company also operates a clinical testing service focused on Inhibin and Activin level measurements.

Inhibin and Activin levels play a crucial role in a number of challenging clinical issues including male infertility, assessment of ovarian reserve, prediction of IVF IVF in vitro fertilization.

IVF
abbr.
in vitro fertilization


IVF 1 In vitro fertilization, see there 2. Intravascular fluid
 outcomes, and differential diagnosis of ovarian cancer. These tests are currently used by numerous clinical and research laboratories worldwide.

Commenting on the acquisition, Gopal V. Savjani, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Diagnostic Systems Laboratories Inc., stated, "The acquisition of OBI positions DSL as the exclusive global provider of diagnostic tests for the measurement of Inhibins and Activins. This acquisition further demonstrates our ongoing commitment to identifying opportunities for innovative medical diagnostic products, both directly and through partnerships with leading industry and academic institutions."

"DSL's strength in the field of reproductive endocrinology combined with OBI's focus and experience in the area of Inhibins and Activins will enable us to accelerate the development of additional products and clinical applications in this field," Savjani added.

Since 1981, DSL has been recognized as a leading source of routine and specialized products for clinical, research, academic and veterinary markets worldwide. DSL currently offers over 190 immunoassay products for fertility and reproduction, androgen assessment, growth factors, bone and mineral metabolism, thyroid function and infectious disease.

DSL products are available in the United States through a direct sales force and worldwide in over 80 countries through an extensive network of subsidiaries, international distributors and strategic partners. DSL is an ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9001-certified company based in Webster, Texas USA.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 8, 2001
Words:335
Previous Article:BASF Announces Alliance With Heidelberg.
Next Article:What is Going on With Web Services? Delphi Group Unveils Market Education, Research, Awareness Campaign for Web Services.



Related Articles
Abbott Laboratories to Distribute American Bio Medica's Rapid Drug Screen to Hospital and Laboratory Markets in the U.S.
Diagnostic Systems Laboratories Inc. is Granted an Exclusive License for Inhibin-A from Oxford Bio-Innovative.
Bio-Reference Laboratories Announces MedUnite Agreement; MedUnite Will Provide On-line Transaction Services to Bio-Reference's CareEvolve Subsidiary.
Bio-reference Laboratories and Roche Diagnostics Announce Strategic Alliance to Manage CareEvolve.
HandyLab Executive to Speak at Partnering for Global Health Forum.
Lockwood Greene Awarded New Orleans BioInnovation Center.
Immunoassay Reagents & Liquid Chromatography Reagents Are Two of the Main Product Segments Analyzed in the Reagents & Supplies for Biotechnology...
Bio-Reference Laboratories Announces Extension of Provider Participation Agreement with United Healthcare to Include Oxford Health Plans Effective...
Clinical Applications and Non-Clinical Applications Are the Major End-Use Segments Analyzed For the Automated and Rapid Microbiological Tests Global...
Electrodes for Medical Devices - Global Strategic Business Report Profiles 166 Companies Including Many Key and Niche Players Worldwide Such as 3M...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles